News | September 22, 2010

Core Curriculum Published for Structural Heart Disease Treatment


September 23, 2010 – The first consensus document for treating structural heart disease has been published by the Society for Cardiovascular Angiography and Interventions (SCAI). The core curriculum and the results of a survey of physicians and training doctors were published Tuesday in Catheterization and Cardiovascular Interventions and JACC Cardiovascular Interventions.

The curriculum, which was endorsed by the American College of Cardiology Foundation and written by interventional specialists from multiple regions, defines training and credentialing requirements along with program standards for practitioners.

Interventional treatments have evolved rapidly during the past decade, and therapies are helping more patients who previously had to undergo open-heart surgery, or who could not be treated at all. With such rapid advancement, SCAI identified a need for uniformity across training programs and specific credentials and standards for practitioners. Currently, a lack of comprehensive training programs prohibits many practitioners from treating structural heart disease, according to the SCAI survey of 107 U.S.-based interventional cardiologists.

"The primary goal of the core curriculum is to provide patients with the highest level of care and treatment available," said Carlos Ruiz, M.D., Ph.D., FSCAI, professor of pediatrics and medicine and director of the division of congenital and structural heart disease at Lenox Hill Heart and Vascular Institute of New York, and lead author of the core curriculum. "The core curriculum will serve training centers and practitioners dedicated to growing their knowledge and skill base for structural heart disease interventions and provide a forum to discuss the latest treatment advancements for structural heart disease to advance and improve patient care."

The curriculum outlines specific training recommendations and skill requirements, including:

• Superb basic catheterization skills with the ability to achieve unusual types of vascular access and manipulate various catheters, balloons and other devices.

• The ability to competently handle potential complications.

• A knowledge base and interventional skills for a variety of complex structural heart diseases, including appropriate device selection, imaging needs, stenting techniques, managing complications and acute and long-term post-procedural care.

"As structural heart disease procedures advance and become increasingly common, it is essential that practitioners acquire the right set of skills and knowledge base," said SCAI Past President Ted Feldman, M.D., FSCAI, director of cardiac catheterization at Evanston Northwestern Healthcare in Evanston, Ill., and chair of the Structural Heart Disease Council. "Patient care will benefit from those who acquire the skills and training outlined in the core curriculum document."

For more information: www.SCAI.org


Related Content

News | Heart Valve Technology

May 9, 2023 — Edwards Lifesciences announced new data from the COMMENCE aortic trial, demonstrating low rates of ...

Home May 09, 2023
Home
News | Heart Valve Technology

February 28, 2023 — On Feb. 27, the U.S. Food and Drug Administration (FDA) issued a Letter to Health Care Providers to ...

Home February 28, 2023
Home
News | Heart Valve Technology

January 23, 2023 — Leakage of the mitral valve due to degenerative prolapse is a common condition known as primary ...

Home January 23, 2023
Home
News | Heart Valve Technology

January 2, 2023 — The U.S. Food and Drug Administration (FDA) has given the approval to market to The Edwards ...

Home January 02, 2023
Home
News | Heart Valve Technology

December 29, 2022 — The Smidt Heart Institute at Cedars-Sinai was named a Mitral Valve Repair Reference Center, a ...

Home December 29, 2022
Home
News | Heart Valve Technology

December 14, 2022 — Edwards Lifesciences identified the top data releases from 2022 that contributed most to shaping ...

Home December 14, 2022
Home
News | Heart Valve Technology

November 22, 2022 — CroíValve has announced the successful First in Human implants of its DUO Tricuspid Coaptation Valve ...

Home November 22, 2022
Home
News | Heart Valve Technology

October 18, 2022 — Foldax, Inc. announced that medtech veteran Gregory D. Casciaro has been named Chief Executive ...

Home October 18, 2022
Home
News | Heart Valve Technology

October 18, 2022 — The United States Food and Drug Administration (FDA) has granted 510(k) clearance to Abiomed for its ...

Home October 18, 2022
Home
News | Heart Valve Technology

September 26, 2022 — Edwards Lifesciences announced the launch of the SAPIEN 3 Ultra RESILIA valve, which incorporates ...

Home September 26, 2022
Home
Subscribe Now